Bausch Health (BHC) Confirms 'Stalking Horse' Agreement to Acquire Substantially All Assets of Synergy Pharmaceuticals (SGYP) Synergy Pharmaceuticals Inc
HON. JAMES L. GARRITY, JR, U.S. BANKRUPTCY JUDGE On Decem (the Petition Date), Synergy Pharmaceuticals, Inc. (Synergy Pharmaceuticals) and
NEW YORK, Dec. 12, 2024 /PRNewswire/ - Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the Company or Synergy ), a biopharmaceutical company focused on the development and commercialization of
Question: Synergy Pharmaceuticals Inc. (SGYPQ) is a biopharmaceutical company focused on thedevelopment and commercialization of novel
NEW YORK, J (GLOBE NEWSWIRE) - Synergy Pharmaceuticals Inc. (Nasdaq:SGYP) and Callisto Pharmaceuticals, Inc. (OTCBB:CLSP)
Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel [ZA]
Search SYNERGY PHARMACEUTICALS, INC. business contracts filed with the Securities and Exchange Commission.
Synergy Pharmaceuticals Inc, a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal
Company) announced today that the Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc.
Comments